An examination of 1-year adherence and persistence rates to antiepileptic medication in children with newly diagnosed epilepsy

Journal of Pediatric Psychology

Volumn 40, Issue 1, 2015, Pages 66-74

  Aylward, Brandon S ^a,b,c   Rausch, Joseph R ^d   Modi, Avani C ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Neurology ^*  (United States)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

adherence; chronic illness; neurological disorders; research design and methods

Indexed keywords

ANTICONVULSIVE AGENT;

CHILD; EPILEPSY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MEDICATION COMPLIANCE; METHODOLOGY; PSYCHOLOGY;

ANTICONVULSANTS; CHILD; EPILEPSY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; RESEARCH DESIGN;

EID: 84925167728     PISSN: 01468693     EISSN: 1465735X     Source Type: Journal    
DOI: 10.1093/jpepsy/jsu010     Document Type: Article

References (36)

1. Barron, T. I., Bennett, K., & Feely, J. (2010). A competing risks prescription refill model of compliance and persistence. Value in Health, 13, 796-804
2. Bassili, A., Omar, T., Zaki, A., Abdel-Fattah, M., & Tognoni, G. (2002). Pattern of diagnostic and therapeutic care of childhood epilepsy in Alexandria, Egypt. International Journal of Quality Health Care, 14, 277-284
3. Besli, G. E., Saltik, S., Erguven, M., Bulut, O., & Abul, M. H. (2010). Status epilepticus in children: Causes, clinical features and short-Term outcome. Pediatrics International: Official Journal of the Japan Pediatric Society, 52, 749-753
4. Blaschke, T. F., Osterberg, L., Vrijens, B., & Urquhart, J. (2011). Adherence to medications: Insights arising from stüs on the unreliable link between prescribed and actual drug dosing histories. Annual Review of Pharmacology and Toxicology, 52, 275-301
5. Burnier, M. (2006). Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. American Journal of Hypertension, 19, 1190-1196
6. Caro, J. J., Speckmann, J. L., Salas, M., Raggio, G., & Jackson, J. D. (1999). Effect of initial drug choice on persistence with antihypertensive therapy: The importance of actual practice data. Canadian Medical Association Journal, 160, 41-46
7. Cramer, J. A., Glassman, M., & Rienzi, B. A. (2002). The relationship between medication compliance and seizures. Epilepsy Behavior, 3, 338-342
8. Cramer, J., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008). Medication compliance and persistence: Terminology and definitions. Value in Health, 11, 44-47
9. Cutler, D. M., & Everett, W. (2010). Thinking outside the pillbox: Medication adherence as a priority for health care reform. New England Journal of Medicine, 362, 1553-1555
10. DiMatteo, M. R., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002). Patient adherence and medical treatment outcomes: A meta-Analysis. Medical Care, 40, 794-811
11. Girard, P, Sheiner, L. B., Kastrissios, H, & Blaschke, T. F. (1996). Do we need full compliance data for population pharmacokinetics analysis? Journal of Pharmacokinetics and Biopharmacology, 24, 265-282
12. Graves, M. M., Roberts, M. C., Rapoff, M., & Boyer, A. (2010). The efficacy of adherence interventions for chronically ill children: A meta-Analytic review. Journal of Pediatric Psychology, 35, 368-382
13. Harter, J. G., & Peck, C. C. (1991). Chronobiology: Suggestions for integrating it into drug development. Annals of the New York Academy of Science, 618, 563-571
14. Haynes, R. B. (1979). Introduction. In D. W. Taylor, & D. C. Sackett (Eds.), Compliance in health care (pp. 1-7). Baltimore, MD: The Johns Hopkins University Press
15. IOM (Institute of Medicine). (2012). Best care at lower cost: The path to continuously learning health care in America. Washington, DC: The National Academics Press
16. Kahana, S., Drotar, D., & Frazier, T. (2008). Metaanalysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. Journal of Pediatric Psychology, 33, 590-611
17. Kalbfleisch, J. D., & Prentice, R. L. (1980). The statistical analysis of failure time data. New York, NY: John Wiley & Sons
18. Modi, A. C., Guilfoyle, S. M., Morita, D. A., & Glauser, T. A. (2011). Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy. Epilepsia, 52, 370-376
19. Modi, A. C., Monahan, S., Daniels, D., & Glauser, T. A. (2010). Development and validation of the Pediatric Epilepsy Medication Self-Management Questionnaire. Epilepsy and Behavior, 18, 94-99
20. Modi, A. C., Morita, D. A., & Glauser, T. A. (2008). One-month adherence in children with new-onset epilepsy: White coat compliance does not occur. Pediatrics, 121, e961-e966
21. Modi, A. C., Pai, A. L., Hommel, K. A., Hood, K. K., Cortina, S., Hilliard, M. E., Drotar, D. (2012). Pediatric self-management: A framework for research, practice, and policy. Pediatrics, 129, e473-485
22. Modi, A. C., Rausch, J. R., & Glauser, T. A. (2011). Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA, 305, 1669-1676
23. Mueller, C. W., & Parcel, T. L. (1981). Measures of socioeconomic status: Alternatives and recommendations. Child Development, 52, 13-20
24. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487-497
25. Pellock, J. M., Smith, M. C., Cloyd, J. C., Uthman, B., & Wilder, B. J. (2004). Extended-release formulations: Simplifying strategies in the management of antiepileptic drug therapy. Epilepsy Behavior, 5, 301-307
26. Quittner, A. L., Modi, A. C., Lemanek, K. L., Ievers-Landis, C. E., & Rapoff, M. A. (2008). Evidencebased assessment of adherence to medical treatments in pediatric psychology. Journal of Pediatric Psychology, 33, 916-936
27. Rapoff, M. A. (2010). Adherence to pediatric medical regimens (2nd ed.). New York, NY: Springer
28. Rohan, J., Drotar, D., McNally, K., Schluchter, M., Riekert, K., Vavrek, P., Kercsmar, C. (2009). Adherence to pediatric asthma treatment in economically disadvantaged African-American children and adolescents: An application of growth curve analysis. Journal of Pediatric Psychology, 35, 394-404
29. Rubio, A., Cox, C., & Weintraub, M. (1992). Prediction of diltiazem plasma concentration curves from limited measurements using compliance data. Clinical Pharmacokinetics, 22, 238-246
30. Shellmer, D., & Zelikovsky, N. (2007). The challenges of using Medication Event Monitoring Technology with pediatric transplant patients. Pediatric Transplantation, 11, 422-428
31. Stevens, G., & Featherman, D. L. (1981). A revised socioeconomic index of occupational status. Social Science Research, 10, 364-395
32. Tremlett, H., Van der Mei, I., Pittas, F., Blizzard, L., Dwyer, T., & Ponson, A. L. (2008). Adherence to the immunomodulatory drugs for multiple sclerosis: Contrasting factors affect stopping drug and missed doses. Pharmacoepidemiology and Drug Safety, 17, 565-576
33. Vrijens, B., Tousset, E., Rode, R., Bertz, R., Mayer, S., & Urquhart, J. (2005). Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosingtime data as input to individually parameterized pharmacokinetic models. Journal of Clinical Pharmacology, 45, 461-467
34. Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J., & Burnier, M. (2008). Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories. British Medical Journal, 336, 1114-1117
35. Wu, Y. P., Aylward, B. S., & Steele, R. G. (2010). The influence of internalizing symptoms on trajectories of medication adherence among pediatric renal and liver transplant recipients. Journal of Pediatric Psychology, 35, 1016-1027
36. Zupanc, M. L. (1996). Update on epilepsy in pediatric patients. Mayo Clinic Proceedings, 71, 899-916